Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alector, Inc.ALEC · Entity 6051 | Chief Medical Officer | August 09, 2021 | August 11, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alector, Inc.
Report date August 09, 2021 · Filed August 11, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 234,319 |
Ending reported balance
After 2021-08-09 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2021-08-09 · Exercise / conversion · Acquired 9,691 · Balance 244,010 Row 2 · 2021-08-09 · Exercise / conversion · Acquired 8,734 · Balance 252,744 Row 3 · 2021-08-09 · Exercise / conversion · Acquired 4,525 · Balance 257,269 Row 4 · 2021-08-09 · Sale · Disposed 22,650 · Balance 234,619 F1: The sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.71 to $27.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Row 5 · 2021-08-09 · Sale · Disposed 300 · Balance 234,319 F1: The sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.71 to $27.83, inclusive. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.16 · Expires 2028-07-02 | Direct | 81,000 |
Reported balance
After 2021-08-09 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-08-09 · Exercise / conversion · Disposed 9,691 · Balance 81,000 F4: Shares subject to the option vest in 48 equal monthly installments beginning on August 2, 2018. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.14 · Expires 2028-11-06 | Direct | 31,250 |
Reported balance
After 2021-08-09 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2021-08-09 · Exercise / conversion · Disposed 8,734 · Balance 31,250 F5: One-fourth of the total number of shares subject to the option grant vested on November 1, 2019, and an additional 1/48th of the shares subject vest monthly thereafter. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.15 · Expires 2029-11-06 | Direct | 84,450 |
Reported balance
After 2021-08-09 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2021-08-09 · Exercise / conversion · Disposed 4,525 · Balance 84,450 F6: Shares subject to the option vest in 48 equal monthly installments beginning on December 6, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.71 to $27.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.71 to $27.83, inclusive.
F4: Shares subject to the option vest in 48 equal monthly installments beginning on August 2, 2018.
F5: One-fourth of the total number of shares subject to the option grant vested on November 1, 2019, and an additional 1/48th of the shares subject vest monthly thereafter.
F6: Shares subject to the option vest in 48 equal monthly installments beginning on December 6, 2019.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 09, 2021 Filed Aug 11, 2021 22:23 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,525 | $0.00 Strike: $17.15 | $0.00 |
DisclosureSEC source: 0001209191-21-050979 · doc4.xml · derivative · entry 8 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,450 Underlying: Common Stock · 4,525 shares Expires 2029-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on December 6, 2019. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 22:23 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 8,734 | $0.00 Strike: $10.14 | $0.00 |
DisclosureSEC source: 0001209191-21-050979 · doc4.xml · derivative · entry 7 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,250 Underlying: Common Stock · 8,734 shares Expires 2028-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth of the total number of shares subject to the option grant vested on November 1, 2019, and an additional 1/48th of the shares subject vest monthly thereafter. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 22:23 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 9,691 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001209191-21-050979 · doc4.xml · derivative · entry 6 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,000 Underlying: Common Stock · 9,691 shares Expires 2028-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on August 2, 2018. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 22:23 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 300 | $27.79 | $8,337.00 |
DisclosureSEC source: 0001209191-21-050979 · doc4.xml · nonDerivative · entry 5 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,319 F1 · kind: The sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.71 to $27.83, inclusive. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 22:23 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 22,650 | $27.17 | $615,429.95 |
DisclosureSEC source: 0001209191-21-050979 · doc4.xml · nonDerivative · entry 4 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,619 F1 · kind: The sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.71 to $27.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 22:23 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 4,525 | $17.15 | $77,603.75 |
DisclosureSEC source: 0001209191-21-050979 · doc4.xml · nonDerivative · entry 3 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,269 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 22:23 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 8,734 | $10.14 | $88,562.76 |
DisclosureSEC source: 0001209191-21-050979 · doc4.xml · nonDerivative · entry 2 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,744 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 22:23 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 9,691 | $8.16 | $79,078.56 |
DisclosureSEC source: 0001209191-21-050979 · doc4.xml · nonDerivative · entry 1 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,010 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 07, 2021 Filed Jul 8, 2021 22:24 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,574 | $0.00 Strike: $17.15 | $0.00 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · derivative · entry 17 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,975 Underlying: Common Stock · 10,574 shares Expires 2029-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on December 6, 2019. Read SEC document |
| July 07, 2021 Filed Jul 8, 2021 22:24 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 11,883 | $0.00 Strike: $10.14 | $0.00 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · derivative · entry 16 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,984 Underlying: Common Stock · 11,883 shares Expires 2028-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: One-fourth of the total number of shares subject to the option grant vested on November 1, 2019, and an additional 1/48th of the shares subject vest monthly thereafter. Read SEC document |
| July 07, 2021 Filed Jul 8, 2021 22:24 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,292 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · derivative · entry 15 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,691 Underlying: Common Stock · 7,292 shares Expires 2028-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on August 2, 2018. Read SEC document |
| July 07, 2021 Filed Jul 8, 2021 22:24 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 17,149 | $39.32 | $674,219.79 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · nonDerivative · entry 13 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,319 F1 · kind: The sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.95 to $39.62, inclusive. Read SEC document |
| July 07, 2021 Filed Jul 8, 2021 22:24 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 7,700 | $38.14 | $293,685.70 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · nonDerivative · entry 12 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,468 F1 · kind: The sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.70 to $38.54, inclusive. Read SEC document |
| July 07, 2021 Filed Jul 8, 2021 22:24 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 4,900 | $37.41 | $183,332.03 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · nonDerivative · entry 11 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,168 F1 · kind: The sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.70 to $37.69, inclusive. Read SEC document |
| July 07, 2021 Filed Jul 8, 2021 22:24 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 10,574 | $17.15 | $181,344.10 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · nonDerivative · entry 10 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,068 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 07, 2021 Filed Jul 8, 2021 22:24 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 11,883 | $10.14 | $120,493.62 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · nonDerivative · entry 9 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,494 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 07, 2021 Filed Jul 8, 2021 22:24 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 7,292 | $8.16 | $59,502.72 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · nonDerivative · entry 8 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,611 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 06, 2021 Filed Jul 8, 2021 22:24 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $17.15 | $0.00 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · derivative · entry 14 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,549 Underlying: Common Stock · 30,000 shares Expires 2029-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on December 6, 2019. Read SEC document |
| July 06, 2021 Filed Jul 8, 2021 22:24 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 1,100 | $40.01 | $44,015.95 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · nonDerivative · entry 7 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,319 F1 · kind: The sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.91 to $40.16, inclusive. Read SEC document |
| July 06, 2021 Filed Jul 8, 2021 22:24 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 10,495 | $39.20 | $411,411.35 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · nonDerivative · entry 6 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,419 F1 · kind: The sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.81 to $39.79, inclusive. Read SEC document |
| July 06, 2021 Filed Jul 8, 2021 22:24 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 3,581 | $38.55 | $138,059.01 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · nonDerivative · entry 5 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,914 F1 · kind: The sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.81 to $38.79, inclusive. Read SEC document |
| July 06, 2021 Filed Jul 8, 2021 22:24 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 1,000 | $37.43 | $37,434.00 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · nonDerivative · entry 4 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,495 F1 · kind: The sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.80 to $37.78, inclusive. Read SEC document |
| July 06, 2021 Filed Jul 8, 2021 22:24 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 3,600 | $35.95 | $129,432.96 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · nonDerivative · entry 3 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,495 F1 · kind: The sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.66 to $36.64, inclusive. Read SEC document |
| July 06, 2021 Filed Jul 8, 2021 22:24 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 10,224 | $35.10 | $358,813.32 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · nonDerivative · entry 2 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,095 F1 · kind: The sales reported by the reporting person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.65 to $35.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (10) to this Form 4. Read SEC document |
| July 06, 2021 Filed Jul 8, 2021 22:24 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 30,000 | $17.15 | $514,500.00 |
DisclosureSEC source: 0001209191-21-046034 · doc4.xml · nonDerivative · entry 1 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,319 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2021 Filed Jul 6, 2021 22:14 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 17,326 | $0.00 Strike: $17.15 | $0.00 |
DisclosureSEC source: 0001209191-21-045623 · doc4.xml · derivative · entry 4 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,549 Underlying: Common Stock · 17,326 shares Expires 2029-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on December 6, 2019. Read SEC document |
| July 02, 2021 Filed Jul 6, 2021 22:14 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 30,000 | $31.14 | $934,200.00 |
DisclosureSEC source: 0001209191-21-045623 · doc4.xml · nonDerivative · entry 3 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,319 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. Read SEC document |
| July 02, 2021 Filed Jul 6, 2021 22:14 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 17,326 | $17.15 | $297,140.90 |
DisclosureSEC source: 0001209191-21-045623 · doc4.xml · nonDerivative · entry 2 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,319 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 22:14 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 26,726 | $22.23 | $594,124.33 |
DisclosureSEC source: 0001209191-21-045623 · doc4.xml · nonDerivative · entry 1 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,993 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.49, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:15 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,600 | $0.00 Strike: $10.14 | $0.00 |
DisclosureSEC source: 0001209191-21-041968 · doc4.xml · derivative · entry 8 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,867 Underlying: Common Stock · 4,600 shares Expires 2028-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on November 1, 2019 and one forty-eighth (1/48th) of the shares vest monthly thereafter. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:15 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 4,600 | $22.18 | $102,048.70 |
DisclosureSEC source: 0001209191-21-041968 · doc4.xml · nonDerivative · entry 5 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,719 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $22.54, inclusive. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:15 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 4,600 | $10.14 | $46,644.00 |
DisclosureSEC source: 0001209191-21-041968 · doc4.xml · nonDerivative · entry 4 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,319 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2021 Filed Jun 21, 2021 20:15 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 12,900 | $0.00 Strike: $10.14 | $0.00 |
DisclosureSEC source: 0001209191-21-041968 · doc4.xml · derivative · entry 7 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,467 Underlying: Common Stock · 12,900 shares Expires 2028-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on November 1, 2019 and one forty-eighth (1/48th) of the shares vest monthly thereafter. Read SEC document |
| June 15, 2021 Filed Jun 21, 2021 20:15 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 17,100 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001209191-21-041968 · doc4.xml · derivative · entry 6 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,983 Underlying: Common Stock · 17,100 shares Expires 2028-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One forty-eighth (1/48th) of the shares subject to the option vested on August 2, 2018, and one forty-eighth (1/48th) of the shares subject to the option vest monthly thereafter. Read SEC document |
| June 15, 2021 Filed Jun 21, 2021 20:15 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 30,000 | $22.07 | $661,953.00 |
DisclosureSEC source: 0001209191-21-041968 · doc4.xml · nonDerivative · entry 3 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,719 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.305, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 15, 2021 Filed Jun 21, 2021 20:15 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 12,900 | $10.14 | $130,806.00 |
DisclosureSEC source: 0001209191-21-041968 · doc4.xml · nonDerivative · entry 2 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 303,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2021 Filed Jun 21, 2021 20:15 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 17,100 | $8.16 | $139,536.00 |
DisclosureSEC source: 0001209191-21-041968 · doc4.xml · nonDerivative · entry 1 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 290,819 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 21:24 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 11,883 | $0.00 Strike: $10.14 | $0.00 |
DisclosureSEC source: 0001209191-21-039571 · doc4.xml · derivative · entry 7 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,284 Underlying: Common Stock · 11,883 shares Expires 2028-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on November 1, 2019 and one forty-eighth (1/48th) of the shares vest monthly thereafter. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 21:24 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,292 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001209191-21-039571 · doc4.xml · derivative · entry 6 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,083 Underlying: Common Stock · 7,292 shares Expires 2028-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One forty-eighth (1/48th) of the shares subject to the option vested on August 2, 2018, and one forty-eighth (1/48th) of the shares subject to the option vest monthly thereafter. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 21:24 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 800 | $20.83 | $16,661.04 |
DisclosureSEC source: 0001209191-21-039571 · doc4.xml · nonDerivative · entry 5 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,719 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.64 to $21.08, inclusive. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 21:24 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 2,200 | $19.89 | $43,752.94 |
DisclosureSEC source: 0001209191-21-039571 · doc4.xml · nonDerivative · entry 4 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,519 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.63 to $20.59, inclusive. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 21:24 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 16,175 | $19.00 | $307,331.47 |
DisclosureSEC source: 0001209191-21-039571 · doc4.xml · nonDerivative · entry 3 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,719 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.61 to $19.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4). Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 21:24 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 11,883 | $10.14 | $120,493.62 |
DisclosureSEC source: 0001209191-21-039571 · doc4.xml · nonDerivative · entry 2 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,894 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 21:24 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 7,292 | $8.16 | $59,502.72 |
DisclosureSEC source: 0001209191-21-039571 · doc4.xml · nonDerivative · entry 1 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,011 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2021 Filed May 25, 2021 23:17 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 784 | $0.00 Strike: $10.14 | $0.00 |
DisclosureSEC source: 0001209191-21-035791 · doc4.xml · derivative · entry 5 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,167 Underlying: Common Stock · 784 shares Expires 2028-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on November 1, 2019 and one forty-eighth (1/48th) of the shares vest monthly thereafter. Read SEC document |
| May 21, 2021 Filed May 25, 2021 23:17 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 14,191 | $0.00 Strike: $8.16 | $0.00 |
DisclosureSEC source: 0001209191-21-035791 · doc4.xml · derivative · entry 4 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,375 Underlying: Common Stock · 14,191 shares Expires 2028-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: One forty-eighth (1/48th) of the shares subject to the option vested on August 2, 2018, and one forty-eighth (1/48th) of the shares subject to the option vest monthly thereafter. Read SEC document |
| May 21, 2021 Filed May 25, 2021 23:17 UTC | Alector, Inc. ALEC · Entity 6051 | SaleCommon Stock | 14,975 | $18.14 | $271,680.94 |
DisclosureSEC source: 0001209191-21-035791 · doc4.xml · nonDerivative · entry 3 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,719 F1 · kind: The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 21, 2021 Filed May 25, 2021 23:17 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 784 | $10.14 | $7,949.76 |
DisclosureSEC source: 0001209191-21-035791 · doc4.xml · nonDerivative · entry 2 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,694 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2021 Filed May 25, 2021 23:17 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionCommon Stock | 14,191 | $8.16 | $115,798.56 |
DisclosureSEC source: 0001209191-21-035791 · doc4.xml · nonDerivative · entry 1 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,910 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2021 Filed May 20, 2021 21:20 UTC | Alector, Inc. ALEC · Entity 6051 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,300 | $0.00 Strike: $10.14 | $0.00 |
DisclosureSEC source: 0001209191-21-034508 · doc4.xml · derivative · entry 5 Paul Robert · CIK 0001757964 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,951 Underlying: Common Stock · 1,300 shares Expires 2028-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on November 1, 2019 and one forty-eighth (1/48th) of the shares vest monthly thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.